Article Text

Download PDFPDF
Right hip gonococcal septic arthritis treatment with successful transition to oral fluoroquinolone
  1. Amy Kiamos1,
  2. Natalie Torrente1,
  3. Michael Sands2 and
  4. Jorge Verdecia2
  1. 1Internal Medicine, University of Florida Health Jacksonville, Jacksonville, Florida, USA
  2. 2Infectious Disease, University of Florida College of Medicine Jacksonville, Jacksonville, Florida, USA
  1. Correspondence to Dr Amy Kiamos; amy.kiamos{at}


We present a case of gonococcal septic arthritis of the right hip diagnosed via synovial fluid cultures. Antimicrobial susceptibility testing of the synovial fluid demonstrated susceptibility to tetracycline, ciprofloxacin, cefixime and ceftriaxone. Our patient was initially treated with ceftriaxone and was successfully de-escalated to oral levofloxacin to complete the treatment. This case is interesting given the rarity of disseminated gonococcal infections in the 21st century and that most clinical isolates of Neisseria gonorrhoeae are increasingly resistant to fluoroquinolones.

  • Global Health
  • Infectious diseases
  • Medical management
  • Sexual transmitted infections (bacterial)
  • Gonorrhoea

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Contributors All authors including AK, NT, JV and MS contributed to conception design, acquisition of data analysis, interpretation of data, drafting the article and revising it for critically important intellectual content. Authors have agreed on the final approval of the version of the manuscript.

  • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

  • Case reports provide a valuable learning resource for the scientific community and can indicate areas of interest for future research. They should not be used in isolation to guide treatment choices or public health policy.

  • Competing interests None declared.

  • Provenance and peer review Not commissioned; externally peer reviewed.